Five Prime Therapeutics and Zai Lab Dosed First Patient in Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers Oct 2, 2018 Life Science
Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry Sep 28, 2018 Life Science
Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences Sep 28, 2018 Life Science
Cellular Bio to Manufacture Novartis CAR-T Drug in China in $40 Million Deal Sep 28, 2018 Life Science
Fosun Pharma Acquires China Rights to Stroke Drug in $32.5 Million Agreement Sep 27, 2018 Life Science
CSPC Pharmaceutical Group Limited and Verastem Oncology Sign Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China Sep 26, 2018 Life Science
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs Sep 26, 2018 Life Science
